GLP-1s, originally developed for diabetes management, have surged in popularity due to their effectiveness in weight loss. This dual-purpose use has led to skyrocketing demand, putting significant financial pressure...
Podcast: Joey Dizenhouse on The Business of Pharmacy Podcast Hear SlateRx President and CEO Joey Dizenhouse on the April 13, 2025, episode of The Business of Pharmacy Podcast. In...
Changing your pharmacy benefits can feel overwhelming, but it doesn’t have to be. With the right partner, a change can be made without an added burden for your team—while...
